Approval · Notice of Compliance 13150 · 2012
IMPROVEST: Notice of Compliance 13150
Issued March 23, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13150
- Date
- March 23, 2012
- Company
- Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate dosing schedule
- Therapeutic class
- Immunological
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMPROVEST | 02369532 | Marketed |